NUS Historical Balance Sheet

NUS Stock  USD 8.08  0.43  5.62%   
Trend analysis of Nu Skin Enterprises balance sheet accounts such as Total Stockholder Equity of 577 M provides information on Nu Skin's total assets, liabilities, and equity, which is the actual value of Nu Skin Enterprises to its prevalent stockholders. By breaking down trends over time using Nu Skin balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Nu Skin Enterprises latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nu Skin Enterprises is a good buy for the upcoming year.

Nu Skin Inventory

188.64 Million

265.3249.9253.5295.8275.9314.4399.9346.2280.0190.2188.6100%
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

About NUS Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Nu Skin Enterprises at a specified time, usually calculated after every quarter, six months, or one year. Nu Skin Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nu Skin and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which NUS currently owns. An asset can also be divided into two categories, current and non-current.

Nu Skin Balance Sheet Chart

At this time, Nu Skin's Good Will is comparatively stable compared to the past year. Intangible Assets is likely to gain to about 83 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 207.4 M in 2025.
Add Fundamental
JavaScript chart by amCharts 3.21.152012201420162018202020222024100M200M400M600M800M1B1.2B1.4B1.6B1.8B2B
JavaScript chart by amCharts 3.21.15Total Assetstotal: 23.9BOther Current Liabtotal: 4.2BTotal Current Liabilitiestotal: 6.2BTotal Stockholder Equitytotal: 11.6BLiabilities And Stockholders Equitytotal: 23.9B

Total Assets

Total assets refers to the total amount of Nu Skin assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nu Skin Enterprises books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Nu Skin balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nu Skin Enterprises are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Liabilities And Stockholders Equity

The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.
Most accounts from Nu Skin's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
At this time, Nu Skin's Good Will is comparatively stable compared to the past year. Intangible Assets is likely to gain to about 83 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 207.4 M in 2025.
 2022 2023 2024 2025 (projected)
Other Current Liabilities202.0M194.8M209.6M207.4M
Total Assets1.8B1.8B1.5B1.2B

Nu Skin balance sheet Correlations

0.610.770.960.940.240.950.750.690.940.30.70.8-0.830.760.920.5-0.740.970.90.720.160.570.53-0.1-0.18
0.610.940.590.42-0.480.370.80.870.330.150.870.57-0.230.040.620.66-0.130.590.860.010.180.13-0.05-0.17-0.16
0.770.940.730.6-0.310.560.890.90.510.080.90.64-0.420.230.780.62-0.320.750.950.220.350.210.16-0.22-0.17
0.960.590.730.880.150.880.660.640.870.280.650.7-0.730.620.910.63-0.60.860.890.570.140.470.46-0.17-0.23
0.940.420.60.880.410.960.560.510.960.270.510.67-0.810.830.870.3-0.80.920.740.830.20.60.58-0.07-0.24
0.24-0.48-0.310.150.410.46-0.2-0.40.530.27-0.40.24-0.650.730.15-0.31-0.740.31-0.170.74-0.110.750.540.460.07
0.950.370.560.880.960.460.580.490.990.410.490.7-0.910.890.830.31-0.860.940.720.860.120.630.550.02-0.26
0.750.80.890.660.56-0.20.580.860.550.020.870.75-0.50.370.670.54-0.390.780.880.330.110.240.3-0.180.0
0.690.870.90.640.51-0.40.490.860.440.081.00.54-0.350.220.620.45-0.270.690.890.190.190.090.14-0.36-0.15
0.940.330.510.870.960.530.990.550.440.380.440.75-0.910.920.810.3-0.860.930.690.880.050.690.630.04-0.14
0.30.150.080.280.270.270.410.020.080.380.070.18-0.540.360.120.22-0.460.290.140.25-0.340.48-0.310.68-0.46
0.70.870.90.650.51-0.40.490.871.00.440.070.55-0.360.220.620.47-0.270.690.890.190.180.090.14-0.36-0.14
0.80.570.640.70.670.240.70.750.540.750.180.55-0.660.650.610.5-0.550.820.710.61-0.190.630.520.050.32
-0.83-0.23-0.42-0.73-0.81-0.65-0.91-0.5-0.35-0.91-0.54-0.36-0.66-0.89-0.66-0.240.95-0.85-0.56-0.840.02-0.81-0.49-0.310.21
0.760.040.230.620.830.730.890.370.220.920.360.220.65-0.890.58-0.02-0.910.820.410.98-0.070.720.680.14-0.03
0.920.620.780.910.870.150.830.670.620.810.120.620.61-0.660.580.48-0.610.860.880.590.450.40.53-0.24-0.27
0.50.660.620.630.3-0.310.310.540.450.30.220.470.5-0.24-0.020.480.00.360.66-0.1-0.090.18-0.180.03-0.12
-0.74-0.13-0.32-0.6-0.8-0.74-0.86-0.39-0.27-0.86-0.46-0.27-0.550.95-0.91-0.610.0-0.81-0.44-0.89-0.09-0.81-0.55-0.310.22
0.970.590.750.860.920.310.940.780.690.930.290.690.82-0.850.820.860.36-0.810.840.80.160.610.56-0.04-0.12
0.90.860.950.890.74-0.170.720.880.890.690.140.890.71-0.560.410.880.66-0.440.840.380.260.30.31-0.27-0.19
0.720.010.220.570.830.740.860.330.190.880.250.190.61-0.840.980.59-0.1-0.890.80.380.070.70.710.10.0
0.160.180.350.140.2-0.110.120.110.190.05-0.340.18-0.190.02-0.070.45-0.09-0.090.160.260.07-0.170.17-0.34-0.21
0.570.130.210.470.60.750.630.240.090.690.480.090.63-0.810.720.40.18-0.810.610.30.7-0.170.380.530.07
0.53-0.050.160.460.580.540.550.30.140.63-0.310.140.52-0.490.680.53-0.18-0.550.560.310.710.170.38-0.320.36
-0.1-0.17-0.22-0.17-0.070.460.02-0.18-0.360.040.68-0.360.05-0.310.14-0.240.03-0.31-0.04-0.270.1-0.340.53-0.32-0.11
-0.18-0.16-0.17-0.23-0.240.07-0.260.0-0.15-0.14-0.46-0.140.320.21-0.03-0.27-0.120.22-0.12-0.190.0-0.210.070.36-0.11
Click cells to compare fundamentals

Nu Skin Account Relationship Matchups

Nu Skin balance sheet Accounts

202020212022202320242025 (projected)
Total Assets2.0B1.9B1.8B1.8B1.5B1.2B
Other Current Liab307.7M274.5M202.0M194.8M209.6M207.4M
Total Current Liabilities542.9M529.7M359.2M328.9M296.6M305.7M
Total Stockholder Equity894.3M912.8M897.3M822.0M651.5M577.0M
Property Plant And Equipment Net653.5M574.6M543.5M523.1M452.2M271.5M
Net Debt97.7M125.4M214.3M351.3M265.2M278.4M
Retained Earnings1.8B1.9B1.9B1.9B1.7B1.0B
Accounts Payable66.2M50.0M54.0M43.5M34.9M34.6M
Cash402.7M339.6M264.7M256.1M186.9M247.4M
Non Current Assets Total1.1B1.0B1.1B1.1B930.3M621.2M
Non Currrent Assets Other50.6M113.1M115.2M99.8M280.6M148.9M
Cash And Short Term Investments423.9M354.8M278.5M267.8M198.0M255.1M
Net Receivables63.4M41.3M47.4M72.9M50.8M36.3M
Common Stock Shares Outstanding52.8M51.4M50.5M49.9M49.7M53.8M
Liabilities And Stockholders Equity2.0B1.9B1.8B1.8B1.5B1.2B
Non Current Liabilities Total519.9M464.0M564.4M655.6M520.9M301.4M
Inventory314.4M399.9M346.2M280.0M190.2M188.6M
Other Current Assets101.6M76.9M87.8M81.2M99.6M70.9M
Other Stockholder Equity(881.8M)(925.2M)(955.8M)(948.6M)(935.8M)(889.0M)
Total Liab1.1B993.7M923.7M984.5M817.5M597.0M
Total Current Assets903.2M873.0M759.9M701.9M538.6M552.9M
Short Long Term Debt Total500.4M465.0M479.0M607.3M452.1M272.2M
Short Term Debt75.0M140.9M54.4M48.9M30M53.7M
Property Plant And Equipment Gross653.5M453.7M444.8M897.6M819.9M860.9M
Accumulated Other Comprehensive Income(64.8M)(73.9M)(86.5M)(100.0M)(124.8M)(118.5M)
Intangible Assets89.5M77.0M66.7M105.3M74.3M83.0M
Other Liab96.8M102.3M106.5M98.3M113.0M72.4M
Other Assets154.0M293.2M175.5M244.4M281.1M152.1M
Long Term Debt305.4M268.8M377.5M478.0M363.6M229.6M
Property Plant Equipment453.6M468.2M453.7M444.8M511.5M275.1M
Current Deferred Revenue35.1M33.1M27.1M20.4M18.3M17.9M
Short Term Investments21.2M15.2M13.8M11.8M11.1M13.6M
Treasury Stock(1.3B)(1.3B)(1.5B)(1.5B)(1.4B)(1.3B)
Net Tangible Assets875.3M894.3M912.8M897.3M1.0B829.4M
Retained Earnings Total Equity1.7B1.8B1.9B1.9B2.2B1.6B
Long Term Debt Total334.5M313.1M274.1M389.6M448.0M321.7M
Capital Surpluse557.5M579.8M601.7M613.3M705.3M500.0M
Non Current Liabilities Other112.3M88.8M76.5M9.0M7.5M7.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.